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Abstract A novel member of the ionotropic ATP receptor gene 
family has been identified in human brain. This 422 amino acid 
long P2X receptor subunit has 62% sequence identity with rat 
P2X5 . Several characteristic motifs of ATP-gated channels are 
present in its primary structure, but this P2Xs-related subunit 
displays a single transmembrane domain. Heterologous expres-
sion of chimeric subunits containing the ( -terminal domain of rat 
P2Xs leads to the formation of desensitizing functional ATP-
gated channels in Xenopus oocytes. The developmental^ 
regulated mRNA, found in two splicing variant forms, is 
expressed at high levels in brain and immune system. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Mammalian P2X receptors belong to a multigene family of 
non-selective cation channels activated by extracellular ATP. 
The seven known members of the rat P2X family can be 
grouped into three functional categories according to their 
pharmacological profiles and to their properties of desensiti-
zation. P2X4 [1] and P2X 3 [2,3] are highly sensitive to a,|3-
methylene-ATP (a(3mATP) and desensitize rapidly; P2X2 [4], 
P2X5 [5,6] and P2X 7 [7] do not respond to a(3mATP below 
100 u\M and do not desensitize, whereas P2X4 [8-10] and 
P2X6 [5] do not respond to a[3mATP, are almost insensitive 
to co-applied non-competitive antagonists suramin and 
PPADS, and show moderate desensitization. Despite the 
fact that high levels of expression of P2X receptors are ob-
served in many central and peripheral tissues, reinforcing the 
concept of an important role for A T P in intercellular commu-
nication [11], much less is known about their human counter-
parts. Excitatory ATP-gated channels play a specific role in 
sensory systems [12-14], therefore the development of sub-
type-specific P2X antagonists with analgesic properties should 
take into account functional differences between mammalian 
species. The reports on the expression of cloned human P2X 
orthologs of P2Xi [15], P2X 3 [16], P2X 4 [17] and P2X 7 [18] 
emphasized both pharmacological and anatomical specificities 
that seriously undermine the relevance of our knowledge 
based on rodent systems for extrapolation to human fast pu-
rinergic transmission. In an effort to complete the genetic in-
ventory of human ionotropic A T P receptors, we report here 
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the identification, heterologous expression and anatomical dis-
tribution of a novel member of the human P2X gene family 
isolated from fetal brain. 
2. Materials and methods 
2.1. Molecular cloning and in vitro translation 
Using the TBLASTN algorithm, virtual screening of the dbEST 
database [19] with the whole coding region of rat P2X4 subunit led 
to the identification of human fetal brain EST sequences encoding a 
novel P2X gene (GenBank accession numbers T80104 and Z43811). 
The clone tagged by EST T80104 was sequenced on both strands and 
was shown to encode a short splicing variant of human P2X subunit 
related to rat P2X5: hP2X5R (Fig. 1). A longer splicing variant of 
hP2X5R was detected in RT-PCR from human cerebellum mRNA 
with exact match primers. The EST clone was engineered to generate 
the long version of hP2X,5R (Fig. 1), deposited in Genbank under 
accession number AF016709. This hP2X5R clone was transferred 
into the .ffmdlll-JVofl sites of eukaryotic vector pcDNA3 (Invitrogen) 
for CMV-driven heterologous expression in HEK-293 cells and Xeno-
pus oocytes. Supercoiled hP2X,5R plasmid was used for in vitro trans-
lation using the TnT system with T7 RNA polymerase (Promega) and 
[35S]cysteine (ICN) according to the manufacturer's specifications. 
2.2. Construction of epitope-tagged hP2Xsjs. subunits and 
immunolocalization 
hP2XsR subunit was epitope-tagged (I1P2X5R-FL) to facilitate the 
immunolocalization of the protein both in situ and in Western blot 
from transfected mammalian cells. The Flag octapeptide 
DYKDDDDK (IBI) was inserted by PCR in the C-terminal domain 
of I1P2X5R using an antisense oligonucleotide primer designed for the 
replacement of its natural stop codon by an artificial in-frame Xho\ 
site (TCACTCGAGCAACGTGCTCCTGTGGGGCT). Full-length 
mutant hP2X5R cDNA was amplified in PCR using Pfu polymerase 
(Stratagene), then ligated to an Xhol-Xbal cassette containing the 
Flag peptide followed by a stop codon [20] in the pcDNA3 vector. 
For transfection of hP2X5R-FL subunits, HEK-293 cells (ATCC 
CRL1573) were grown in DMEM-10% heat-inactivated fetal bovine 
serum (Wisent, St Bruno, Quebec) containing penicillin and strepto-
mycin. Freshly plated cells reaching 30-50% confluence were used for 
transient transfection using the calcium phosphate method on 90 mm 
dishes with 10 u.g supercoiled plasmid/106 cells. 
For immunofluorescence, transfected HEK-293 cells (48-72 h post-
transfection time) were plated at 50-70% confluence in poly-lysine-
coated chambers. Adherent cells were washed in PBS and fixed for 
20 min at room temperature with 4% paraformaldehyde in 0.1 M 
phosphate buffer, pH 8.0. After blocking non-specific sites with 2% 
normal goat serum, fixed cells were incubated with anti-Flag mono-
clonal antibody (mAb) M2 (1 |ig/ml, IBI) for 1 h at room temperature 
in 0.05 M Tris-saline buffer pH 7.2 containing 0.2% Triton X-100, 5% 
normal goat serum and 5% dry milk powder. Bound primary anti-
bodies were detected by immunofluorescence after 1 h incubation with 
Texas red-labeled goat anti-mouse (2 (ig/ml) secondary antibodies 
(ImmunoResearch Labs). 
For high resolution analysis of hP2X5R-FL subcellular distribution, 
we used a Zeiss Laserscan Inverted 410 confocal microscope equipped 
with an argon-krypton laser set at 580 nm for Texas red. Serial images 
(512x512 pixels) acquired as single optical sections were averaged 
over 32 scans/frame and processed with the Zeiss CLMS software 
package. 
For Western blots, transfected cells were lifted in Hanks' modified 
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calcium-free medium with 20 mM EDTA, pelleted at low speed and 
homogenized in 10 volumes of 10 mM HEPES buffer pH 7.4 contain-
ing the protease inhibitors phenylmethylsulfonyl fluoride (0.2 mM) 
and benzamidine (1 mM). Lysates were pelleted at 14000 Xg for 
5 min to remove cell debris before protein assay and crude membrane 
proteins in supernatants were solubilized with SDS-containing loading 
buffer. About 150 (ig of protein/lane were run on 12% SDS-PAGE, 
then transferred to nitrocellulose. Immunoprobing was performed 
with mouse mAb M2 (1 Lig/ml) followed by peroxidase-labeled sec-
ondary antibodies for visualization by enhanced chemiluminescence 
(Amersham). 
croinjection [21] of 10 ng cDNA of hP2X5 or h-rP2X5 chimera in 
pcDNA3 vector. After 2-4 days of expression at 19°C in Barth's 
solution containing 10 Ltg/ml gentamicin, oocytes were recorded in 
two-electrode voltage-clamp configuration using a OC-725B amplifier 
(Warner Inst.). Signals were acquired and digitized at 500 Hz using a 
Macintosh Ilci equipped with an A/D card NB-MI016XL (National 
Instruments) then traces were post-filtered at 100 Hz in Axograph 
(Axon Instruments). Agonists dissolved in Ringer's solution contain-
ing 115 mM NaCl, 2.5 mM KC1, 1.8 mM CaCl2 in 10 mM HEPES 
pH 7.4 at room temperature were applied on oocytes by perfusion in 
constant flow (10 ml/min). 
2.3. Functional expression of h-rP2X5 chimera in Xenopus oocytes 
The domain of hP2X5R containing amino acids 1-318 was fused to 
the PCR-amplified domain corresponding to amino acids 318^155 of 
rat P2X5 using the natural BamHI site of hP2X5R to generate the 
chimera h-rP2X5. Oocytes surgically removed from mature Xenopus 
laevis frogs were treated for 2 h at room temperature with type II 
collagenase (Gibco-BRL) in Barth's solution under agitation. Selected 
stage IV-V oocytes were defolliculated manually before nuclear mi-
2.4. RT-PCR detection ofhP2X5R mRNA from human cerebellum and 
lymphocytes 
Total RNA from post-mortem adult human cerebellar cortex and 
adult lymphocytes were isolated using Trizol reagent (Gibco-BRL). 
Then 5 ng of each RNA was subjected to random-primed reverse-
transcription with Superscript (Gibco-BRL). Around 100 ng of RT-
cDNA was used as template for PCR with the following primers: 
forward TTCGACTACAAGACCGAGAAGT (PI, see Fig. IB) and 
GGCACGAGGGTCCGCAAGCCCGGCTOAGAGCGCGCCATGGGGCAGGCGGGCTGCAAGGGGCTCTGCCTGTCGCTC 7 5 
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Fig. 1. Molecular cloning of a novel member of the human P2X ATP gene family: hP2X5R. A: Nucleotide sequence and ORF domain. Poten-
tial intracellular phosphorylation sites are indicated, as well as cysteine residues (bold) and JV-glycosylation sites (italics) in the putative extracel-
lular domain of the subunit. The spliced domain of 24 amino acids (Gly97-Glu120), absent in the short variant from brain, is boxed. The puta-
tive splicing site of missing TM2 sequence is indicated by the arrowhead. B: Alignment of human and rat P2X5 amino acid sequences and 
positions of PCR primers based on hP2X5R primary structure. 
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Fig. 2. Heterologous expression and immunodetection of hP2XjR 
subunits. A: In vitro translation of recombinant wild-type (1) and 
Flag-tagged hP2X5R (2). B: Detection in Western blot of epitope-
tagged hP2X5R (1) and rat P2X4 (2) from transfected HEK-293 
cells. 
reverse CTTGACGTCCTTCACATTGT (P2) to amplify the region 
corresponding to nucleotides 75-671 around the splicing event, as well 
as forward GAGGCCGAAGACTTCACCAT (P3) and reverse 
CCTCGTACTTCTTGTCACGG (P4) to detect the expression of a 
complete second transmembrane domain (TM2). Non-RT samples 
amplified in the same conditions provided the negative controls. In-
tegrity and representativity of RT-cDNA were checked by amplifica-
tion of human P2X7 subunit message [18] and human P2X4 message 
[17] with appropriate primers in lymphocytes and in cerebellum, re-
spectively (data not shown). 
2.5. Distribution of IIP2XSR transcripts in human tissues 
Known amounts of mRNA blots corresponding to equivalent tran-
scription levels of housekeeping genes from various fetal and adult 
human tissues (Masterblot, Clontech) were probed with full-length 
random-primed [32P]hP2X5R cDNA at high stringency (final elution 
at 65°C in 0.3XSSC buffer). Hybridization signals were quantitated 
using a Storm phosphorimager and the ImageQuant application (Mo-
lecular Dynamics) before subtraction of background and normaliza-
tion of transcription levels. 
3. Results and discussion 
The longest reading frame of hP2X5R cDNA encodes a 
protein of 422 amino acids that displays 62% sequence iden-
tity with rat P2X5 and several unique motifs conserved in all 
P2X receptor subunits (Fig. 1). In the intracellular N-terminal 
domain, hP2X5R displays an highly conserved threonine resi-
due (Thr18), potentially susceptible to phosphorylation by 
protein kinase C. In addition, a serine residue (Ser12) is found 
in a consensus site for phosphorylation by casein kinase II. In 
the putative extracellular domain of hP2X5R, all 10 cysteine, 
all proline, 91% of glycine and 75%> of lysine residues are 
present at homologous positions in all P2X subunits, indicat-
ing their critical roles in the folding and function of this sen-
sor region. We checked the real position of the predicted stop 
codon by in vitro translation as well as Western blot (Fig. 2). 
The recombinant subunit and its epitope-tagged mutant mi-
grate at a Mr of 49 ±2 kDa and 51 ±2 kDa, respectively, in 
agreement with the calculated MW of 47 kDa for wild-type 
hP2X5R (Fig. 2B). At least one of the 3 AMinked glycosylation 
consensus sites present in the extracellular domain of hP2X5R 
is used, according to the difference of MT (up to 11 kDa) 
between in vitro translated hP2X5R and hP2XsR expressed 
in transfected HEK-293 cells (Fig. 2B,C). The multiple bands 
observed in Western blot from transfected cells could be due 
to the co-expression of several glycosylated forms of hP2X5R 
(Fig. 2B). 
The integrity of the protein was also checked by detection 
of heterologously expressed epitope-tagged hP2X5R mutants 
using in situ immunofluorescence (Fig. 2AFig. 3). Analysis 
of the subcellular localization of hP2X5R-FL in HEK-293 cells 
using confocal microscopy indicated a correct targeting of the 
subunit to the plasma membrane (Fig. 3), quantitatively sim-
ilar to the surface distribution of the functional P2X receptors 
rat P2Xi-FL and rat P2X4-FL [14]. When expressed in Xeno-
pus oocytes, homomeric hP2X5 channels do not respond to 
extracellular ATP applied at concentrations up to 1 mM, 
However, the chimera h-rP2X5, made of the N-terminal do-
main of hP2X5 linked to the C-terminal domain of rat P2X5, 
revealed the formation of cationic ATP-gated ion channels 
(Fig. 4). These channels run down rapidly and do not recover 
fully from desensitization after extensive washing of agonist 
lasting several minutes in constant perfusion (Fig. 4). There-
[ATP] = lOOuM 
\ 
Fig. 3. Subcellular distribution of hP2X5R subunits expressed in 
HEK-293 cells using confocal microcope immunofluorescence. Ar-
rows indicate the localization of hP2X5R subunits on the plasma 
membrane. 
Fig. 4. Functional expression of the chimera h-rP2Xs in Xenopus 
oocytes. Fast and desensitizing inward currents evoked by 100 uM 
extracellular ATP were recorded after 2-4 days of expression in 
two-electrode voltage-clamp configuration (holding potential 
Vh = —100 mV). Repeated applications of agonist at time to +500 s 
or to +700 s showed profound desensitization of the chimeric ATP-
gated channels. 
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fore, despite the high sequence similarity with non-desensitiz-
ing wild-type rat P2X5 (62%), this chimeric channel displays a 
unique functional property not found in any other known 
homomeric or heteromeric subtypes. These data suggest that 
the kinetics of desensitization of P2X channels is dependent 
on subtle rules of complementarity between the N-terminal 
and the C-terminal halves of the subunits, as has been shown 
for P2Xj and P2X2 [23]. 
We observed the expression of a splicing variant identified 
in fetal and adult brain by RT-PCR (Fig. 5), differing from 
the long form of hP2XsR by the absence of a cassette of 24 
amino acids, corresponding to the domain Gly97-Glu120 (Fig. 
1). This cassette contains one of the 10 extracellular cysteines, 
so the expression of this short variant is due either to some 
inaccuracy in the intron/exon splicing mechanisms or to some 
functional regulation. Interestingly, the region including ami-
no acids Ala328-Ala349 in rat P2X5, corresponding to the pre-
TM2 region and the outer mouth of TM2 in P2X receptor 
subunits [22], is consistently absent in hP2X5R mRNA from 
brain and from lymphocytes, despite the high sensitivity of the 
RT-PCR method used and the high levels of expression in 
both tissues (Fig. 6). Furthermore, attempts to detect a var-
iant of hP2X5R with a complete TM2 failed in tissues where 
homologous rat P2X5 has been localized by in situ hybrid-
ization [5], like spinal cord and trigeminal sensory ganglia 
(data not shown). 
To assess the anatomical distribution, we measured the rel-
ative levels of transcription of the hP2X5R gene in quantitative 
mRNA dot blot. Hybridization signals from a variety of fetal 
and adult tissues showed widespread but selective distribution 
of central and peripheral hP2X5R transcripts (Fig. 6). The two 
systems primarily involved in the processing of extracellular 
information, i.e. the central nervous system and the immune 
system, show the highest levels of hP2X5R expression. We 
measured a dramatic developmental down-regulation of 
hP2X5R mRNA in the thymus from the fetal to the adult stage 
(Fig. 6) that could be related to the massive apoptosis of 
immature thymocytes occurring during negative selection 
[24]. P2Xi mRNA has been found to be upregulated during 
the apoptosis of immature thymocytes [25] so the distribution 
of I1P2X5 argues strongly for an important role of P2X re-
ceptors in clonal deletion of immune cells. With only one 
transmembrane region, the structure of hP2X5R is reminiscent 
of tyrosine kinase receptors [26]. We speculate that hP2X5R 
could be activated by the binding of an unidentified extracel-
lular ligand or could be involved in the regulation of channel 
subunit interactions both in the brain and in the immune 
system. 
The rat P2X5 is the neuronal subunit with the most limited 
Fig. 5. The hP2X5R transcripts are expressed in two alternatively 
spliced forms in human brain as detected in RT-PCR amplification 
(1, primers P1+P2). The full-length form is predominantly found in 
lymphocytes (3, primers P1+P2). Both hP2XsR mRNA populations 
from brain (2, primers P3+P4) and lymphocytes (4, primers P3+P4) 
encode subunits with a single transmembrane domain. 
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Fig. 6. Relative levels of expression of central and peripheral 
hP2X5R mRNA in human fetal (shaded bars) and adult tissues us-
ing hybridization of a full-length cDNA probe on poly(A)+ RNA 
blot. 
distribution, so one striking difference between rat and human 
P2X receptor genes is the high expression of hP2X5R in the 
brain and in peripheral tissues. The developmental regulation 
of levels of transcription and the tissue specificity observed in 
mRNA splicing do not seem compatible with the expression 
of a processed pseudogene [27]. However, it is possible that 
undetected splicing variants of hP2X5R with two transmem-
brane domains would form functional human P2X5 channels 
in homomeric form or assemble in heteromeric complexes in 
specific cell types. In any case, as has been described in other 
classes of multimeric integral proteins, i.e. the neurotrophin 
receptors [28], the steroid receptors [29] and voltage-gated K 
channels [30], the regulatory effect of a dominant negative 
truncated hP2X5R subunit on human heteromeric ATP-gated 
channels remains to be investigated. 
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